ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT00091598 · COMPLETED

Trial details

NCT number: NCT00091598
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2004-01-01
Primary completion: 2006-02-01
Enrollment: 372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.